Cemex (NYSE:CX) Stock

Cemex

Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services.

Cemex SAB de CV

C5 ACQUISITION CORP L A

CXApp Inc

CALIBRE MINING CORP ORD by Calibre Mining Corp.

Calibre Mining Corp

CORIX BIOSCIENCE INC by Corix Bioscience, Inc.

Corix Bioscience Inc

Cardxx Inc

CYPHER METAVERSE INC by CYPHER METAVERSE INC.

Cypher Metaverse Inc

Crexendo Inc

MFS High Income Municipal Trust Common Stock

Mfs High Income Municipal Trust

COMPUTER & TECHS HLDGS by Computer & Technologies Holdings Ltd.

Computer And Technologies Holdings Ltd

MFS Investment Grade Municipal Trust Common Stock

Mfs Investment Grade Municipal Trust

COMMODORE APPLIED TECHS by Commodore Applied Technologies, Inc.

CHINA XLX FERTILISER LTD by China XLX Fertiliser Ltd.

Sprinklr Inc

CargoX

Core Lithium Ltd

CHINA RES MIXC LIFESTYLE by CHINA RES MIXC LIFESTYLE SVCS LTD.

Listed Funds Trust Teucrium 2x Daily Corn ETF

WisdomTree China ex-State-Owned Enterprises Fund

Crane NXT Co

Covalent X Token - United States Dollar

CoreCivic Inc

C21 INVESTMENTS INC ORD by C21 Investments Inc.

C21 Investments Inc

CMX GOLD & SILVER CRP ORD by CMX Gold & Silver Corp

CMX Gold & Silver Corp

RBC Capital analyst Anthony Codling maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Underperform and lowers the price target from $6 to $5.

News

Price Target

Analyst Ratings

RBC Capital Maintains Underperform on Cemex, Lowers Price Target to $5

Goldman Sachs analyst Bruno Amorim maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Buy and raises the price target from $8 to $9.

Goldman Sachs Maintains Buy on Cemex, Raises Price Target to $9

Asset Sales

Mexico's Cemex Is Reportedly Exploring A Sale Of Its Columbian Unit

RBC Capital analyst Anthony Codling maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Underperform and raises the price target from $5 to $6.

RBC Capital Maintains Underperform on Cemex, Raises Price Target to $6

Management

Cemex CEO Fernando González Decides To Retire; Jaime Muguiro Appointed As New CEO, Effective April 1, 2025

WIIM

Cemex shares are trading higher after the company reported better-than-expected Q4 EPS results.

Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.04 by 300 percent. This is a 153.33 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $3.811 billion which missed the analyst consensus estimate of $3.894 billion by 2.14 percent. This is a 89.72K percent increase over sales of $4.243 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Cemex Q4 2024 GAAP EPS $0.16 Beats $0.04 Estimate, Sales $3.811B Miss $3.894B Estimate

AAMI

AFRM

AGCO

AMRK

AMZN

APTV

BILL

CCEC

CIGI

CLFD

CLSK

CRNC

CTLP

DOCS

EMBC

ENTG

EXPE

EXPO

FARM

FBIN

FTNT

GOOS

GPRO

GTES

GTIM

HUBG

IBEX

IDCC

IIIV

ILMN

INTR

KVUE

LADR

LESL

Laboratory Corporation Of America Holdings

LION

LITE

LIVE

LQDT

LSPD

LTRX

MAGN

MATW

MCFT

MCHP

MKTX

MPWR

MSGE

MTSI

Earnings Scheduled For February 6, 2025

RBC Capital analyst Anthony Codling downgrades Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) from Sector Perform to Underperform and lowers the price target from $6 to $5.

Downgrades

RBC Capital Downgrades Cemex to Underperform, Lowers Price Target to $5

Scotiabank analyst Francisco Suarez maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Sector Outperform and lowers the price target from $8.9 to $8.2.

Scotiabank Maintains Sector Outperform on Cemex, Lowers Price Target to $8.2

Scotiabank analyst Francisco Suarez maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Sector Outperform and lowers the price target from $10 to $8.9.

Scotiabank Maintains Sector Outperform on Cemex, Lowers Price Target to $8.9

RBC Capital analyst Anthony Codling maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Sector Perform and lowers the price target from $6.5 to $6.

RBC Capital Maintains Sector Perform on Cemex, Lowers Price Target to $6

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Vertical Research analyst Kevin McCarthy downgraded the rating for Celanese Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) from Hold to Sell and announced a $130 price target. Celanese shares closed at $129.97 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Raymond James analyst Simon Leopold downgraded Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) from Strong Buy to Outperform and slashed the price target from $17 to $14. Harmonic shares closed at $14.82 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Adrian Huerta downgraded CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) from Overweight to Neutral and lowered the price target from $7 to $6. Cemex shares closed at $5.46 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>TD Cowen analyst Oliver Chen downgraded the rating for Tapestry, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPR#NYSE">TPR</a>) from Buy to Hold and maintained the price target of $52. Tapestry shares closed at $50.47 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>B. Riley Securities analyst Mike Crawford downgraded Redwire Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) from Buy to Neutral and raised the price target from $8 to $9.5. Redwire shares closed at $9.19 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying CE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="523" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29095706/image-302-1024x523.png" alt="" class="wp-image-619542" style="width:640px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29095706/image-302-1024x523.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29095706/image-302-300x153.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29095706/image-302-768x392.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29095706/image-302.png 1312w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More:<a href="https://www.benzinga.com/news/24/10/41598310/jim-cramer-avoid-this-consumer-cyclical-stock-buy-lam-research"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41598310/jim-cramer-avoid-this-consumer-cyclical-stock-buy-lam-research">Jim Cramer: &#8216;Avoid&#8217; This Consumer Cyclical Stock, Buy Lam Research</a></li>
</ul>

Markets

Trading Ideas

HLIT

This Celanese Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) reported worse-than-expected third-quarter <a href="https://www.benzinga.com/quote/CX/earnings">financial results on Monday</a>.
Cemex reported quarterly earnings of 14 cents per share which missed the analyst consensus estimate of 19 cents per share. The company reported quarterly sales of $4.090 billion which missed the analyst consensus estimate of $4.305 billion.
Cemex shares fell 8.7% to close at $5.46 on Monday.
These analysts made changes to their price targets on Cemex following earnings announcement.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e99cf63d89aa400014fa922/adrian-huerta">JP Morgan analyst Adrian Huerta</a> downgraded Cemex from Overweight to Neutral and lowered the price target from $7 to $6.</li>
<li>Barclays analyst Benjamin Theurer maintained Cemex with an Overweight and lowered the price target from $9 to $8.</li>
</ul>
Considering buying CX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="512" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png" alt="" class="wp-image-619379" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-1024x512.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298-768x384.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29090532/image-298.png 1285w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41592226/dow-surges-over-250-points-ahead-of-alphabet-pfizer-earnings-investor-sentiment-improves-fear-index">Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Cemex Analysts Slash Their Forecasts After Q3 Results

Barclays analyst Benjamin Theurer maintains Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) with a Overweight and lowers the price target from $9 to $8.

Barclays Maintains Overweight on Cemex, Lowers Price Target to $8

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Needham cut ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) price target from $92 to $87. Needham analyst Quinn Bolton maintained a Buy rating. ON Semiconductor shares closed at $72.24 on Monday. See how other analysts view this stock.</li>
<li>HC Wainwright &amp; Co. lowered the price target for Ekso Bionics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EKSO#NASDAQ">EKSO</a>) from $10 to $9. HC Wainwright &amp; Co. analyst Swayampakula Ramakanth maintained a Buy rating. Ekso Bionics shares closed at $1.13 on Monday. <a href="https://www.benzinga.com/quote/EKSO/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham slashed the price target for TransMedics Group, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) from $208 to $109. Needham analyst Mike Matson maintained a Buy rating. TransMedics shares closed at $126.24 on Monday. <a href="https://www.benzinga.com/quote/TMDX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Telsey Advisory Group raised V.F. Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) price target from $19 to $21. Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating. V.F. Corporation shares settled at $17.03 on Monday. <a href="https://www.benzinga.com/quote/VFC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan cut CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) price target from $7 to $6. JP Morgan analyst Adrian Huerta downgraded the stock from Overweight to Neutral. CEMEX shares closed at $5.46 on Monday. <a href="https://www.benzinga.com/quote/CX/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Barclays raised Summit Materials, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUM#NYSE">SUM</a>) price target from $45 to $52. Barclays analyst Adam Seiden upgraded the stock from Equal-Weight to Overweight. Summit Materials shares closed at $45.63 on Monday. <a href="https://www.benzinga.com/quote/SUM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley boosted the price target for Planet Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) from $84 to $89. Morgan Stanley analyst Megan Alexander maintained an Overweight rating. Planet Fitness shares settled at $81.25 on Monday. <a href="https://www.benzinga.com/quote/PLNT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BTIG raised Agilysys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) price target from $118 to $124. BTIG analyst Matthew Vanvliet maintained a Buy rating. Agilysys shares closed at $111.49 on Monday. <a href="https://www.benzinga.com/quote/AGYS/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities increased the price target for KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) from $150 to $155. JMP Securities analyst Devin Ryan maintained a Market Outperform rating. KKR shares closed at $140.75 on Monday. <a href="https://www.benzinga.com/quote/KKR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>BTIG boosted Boot Barn Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) price target from $165 to $185. BTIG analyst Janine Stichter maintained a Buy rating. Boot Barn shares closed at $161.22 on Monday. <a href="https://www.benzinga.com/quote/BOOT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying BOOT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="551" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29075842/image-294-1024x551.png" alt="" class="wp-image-619173" style="width:608px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29075842/image-294-1024x551.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29075842/image-294-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29075842/image-294-768x413.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/29075842/image-294.png 1221w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41592226/dow-surges-over-250-points-ahead-of-alphabet-pfizer-earnings-investor-sentiment-improves-fear-index">Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

AGYS

BOOT

EKSO

PLNT

TMDX

Boot Barn To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday

JP Morgan analyst Adrian Huerta downgrades Cemex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) from Overweight to Neutral and lowers the price target from $7 to $6.

JP Morgan Downgrades Cemex to Neutral, Lowers Price Target to $6

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 300 points on Monday.
The Dow traded up 0.77% to 42,440.12 while the NASDAQ rose 0.46% to 18,603.67. The S&amp;P 500 also rose, gaining, 0.43% to 5,832.99.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/10/41573022/how-to-earn-500-a-month-from-ford-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Ford Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Financials shares rose by 1.2% on Monday.
In trading on Monday, energy shares fell by 0.7%.
Top Headline
Koninklijke Philips NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) reported third-quarter adjusted EPS of 0.32 euros (or $0.35), missing the consensus of 0.35 euros. The Dutch conglomerate reported sales of 4.38 billion euros ($4.74 billion), down 2% year over year and missing the consensus of 4.54 billion euros.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Healthcare Triangle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares shot up 106% to $1.19 &nbsp;after the company disclosed in a filing that it acquired the business, assets, and operations relating to cloud and technology domain of Securekloud Technologies.</li>
<li>Shares of Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) got a boost, surging 70% to $13.08 &nbsp;after the company reported preliminary results from its clinical trial of RF Ablation technology where 100% of its responder group was able to eliminate opioid use and reduce pain scores.</li>
<li>Evoke Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares were also up, gaining 52% to $7.78 after the company announced the presentation of GLP-1 data for users with diabetic gastoparesis using GIMOTI and showed statistically significant improvements.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) shares dropped 16% to $26.52 after the company reported third-quarter EPS and sales below estimates and revised its 2024 outlook due to weak demand in China.</li>
<li>Shares of Borr Drilling Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>) were down 7% to $4.38. The stock may be moving on continued weakness following Friday&#8217;s reported preliminary third-quarter financial results.</li>
<li>CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) was down, falling 9% to $5.46 following weak quarterly results.</li>
</ul>
Commodities In commodity news, oil traded down 6% to $67.49 while gold traded down 0.1% at $2,754.40.
Silver traded up 0.2% to $33.850 on Monday, while copper fell 0.1% to $4.3655.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 gained 0.41%, Germany's DAX rose 0.35% and France's CAC 40 rose 0.79%. Spain's IBEX 35 Index rose 0.77%, while London's FTSE 100 rose 0.45%.
Retail sales in Spain rose by 4.1% year-over-year in September, while retail sales volumes in the UK fell by 6% in October following a 4% increase in September.
Asia Pacific Markets
Asian markets closed higher on Monday, with Japan's Nikkei 225 gaining 1.82%, Hong Kong's Hang Seng Index gaining 0.05%, China's Shanghai Composite Index gaining 0.68% and India's BSE Sensex surging 0.76%.
Hong Kong&#8217;s trade deficit shrank to $53.2 billion in September from $64.6 billion in the year-ago month.
Economics
The Federal Reserve Bank of Dallas&#8217; general business activity index for manufacturing in Texas rose to -3 in October compared to a reading of -9 in the earlier month.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41570746/top-3-real-estate-stocks-that-may-surge-in-q4">Top 3 Real Estate Stocks That May Surge In Q4</a></li>
</ul>

Equities

Eurozone

Commodities

AMIX

BORR

EVOK

HCTI

S&P 500 Moves Higher; Philips Shares Plunge After Q3 Earnings

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 200 points on Monday.
The Dow traded up 0.52% to 42,333.84 while the NASDAQ rose 0.43% to 18,598.02. The S&amp;P 500 also rose, gaining, 0.31% to 5,826.12.
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/10/41573022/how-to-earn-500-a-month-from-ford-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Ford Stock Ahead Of Q3 Earnings</a>
Leading and Lagging Sectors Utilities shares rose by 1.1% on Monday.
In trading on Monday, energy shares fell by 1%.
Top Headline
ON Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) posted better-than-expected earnings for the third quarter on Monday.
The company posted a revenue decline of 19.2% year-on-year to $1.76 billion, beating the analyst consensus estimate of $1.75 billion. The adjusted EPS of 99 cents beat the analyst consensus estimate of 97 cents.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Healthcare Triangle, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) shares shot up 159% to $1.50 after the company disclosed in a filing that it acquired the business, assets, and operations relating to cloud and technology domain of Securekloud Technologies.</li>
<li>Shares of Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) got a boost, surging 78% to $13.73 after the company reported preliminary results from its clinical trial of RF Ablation technology where 100% of its responder group was able to eliminate opioid use and reduce pain scores.</li>
<li>Evoke Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) shares were also up, gaining 82% to $9.34 after the company announced the presentation of GLP-1 data for users with diabetic gastoparesis using GIMOTI and showed statistically significant improvements.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>) shares dropped 17% to $26.16 after the company reported third-quarter EPS and sales below estimates and revised its 2024 outlook due to weak demand in China.</li>
<li>Shares of Borr Drilling Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BORR#NYSE">BORR</a>) were down 11% to $4.1987. The stock may be moving on continued weakness following Friday&#8217;s reported preliminary third-quarter financial results.</li>
<li>CEMEX, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CX#NYSE">CX</a>) was down, falling 10% to $5.36 following weak quarterly results.</li>
</ul>
Commodities In commodity news, oil traded down 5.4% to $67.88 while gold traded up 0.1% at $2,755.50.
Silver traded up 0.3% to $33.890 on Monday, while copper fell 0.1% to $4.3660.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.10%, Germany's DAX fell 0.02% and France's CAC 40 rose 0.39%. Spain's IBEX 35 Index rose 0.37%, while London's FTSE 100 rose 0.16%.
Retail sales in Spain rose by 4.1% year-over-year in September, while retail sales volumes in the UK fell by 6% in October following a 4% increase in September.
Asia Pacific Markets
Asian markets closed higher on Monday, with Japan's Nikkei 225 gaining 1.82%, Hong Kong's Hang Seng Index gaining 0.05%, China's Shanghai Composite Index gaining 0.68% and India's BSE Sensex surging 0.76%.
Hong Kong&#8217;s trade deficit shrank to $53.2 billion in September from $64.6 billion in the year-ago month.
Economics
The Federal Reserve Bank of Dallas&#8217; general business activity index for manufacturing in Texas rose to -3 in October compared to a reading of -9 in the earlier month. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41570746/top-3-real-estate-stocks-that-may-surge-in-q4">Top 3 Real Estate Stocks That May Surge In Q4</a></li>
</ul>

Intraday Update

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Guidance

Dividends

Buybacks

Cemex CEO Sees Building On Dividend, Share Buyback Program

Press Releases

Fortune Recognizes Cemex for the Fourth Time as a Company That Is Changing the World

EU Backs Pioneering CO2 Capture Project at Cemex's Rüdersdorf Cement Plant

Cemex Recognized at COP29 for Solar Clinker Breakthrough

Cemex Announces CEO Transition

Cemex Announces Senior Level Organizational Changes

Cemex celebrates 25 years of biodiversity conservation and restoration at El Carmen Nature Reserve

Cemex Recognized as One of the World's Most Ethical Companies®

Cemex showcases significant operational and sustainability advancements in its 2024 Integrated Report

Jaime Muguiro Begins Tenure as CEO of Cemex

Cautious Optimism for Building Products Distribution Rising as Sustained Demand for New Residential Construction Expected

CAPS

TTAM

Cementos Pacasmayo S.A.A. American Depositary Shares (Each representing five Common Shares)

Comments

Cemex

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL